Other studies highlighted the oncogenic function of the methyltransferase EZH2 in castration-resistant prostate cancer cells, where EZH2 acts as a coactivator for critical transcription factors, including the androgen receptor [56,57]. This evidence concerns the gene AR and prostate carcinoma.